BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

StemCell Technologies Inc. Release: StemSpan™ SFEM II, for Unparalleled Hematopoietic Cell Expansion Performance


12/3/2012 3:36:25 PM

December 03, 2012 -- STEMCELL Technologies Inc. announced this week the launch of StemSpan™ SFEM II, a new hematopoietic stem cell expansion medium for maximum expansion of CD34+ cells from human cord blood and bone marrow. StemSpan™ SFEM II provides on average 40% higher expansion of hematopoietic progenitors compared to six leading commercially available serum-free media from different suppliers. The unparalleled performance of StemSpan™ SFEM II allows researchers to expand precious human samples and generate large numbers of primitive hematopoietic progenitors for further research applications.

“StemSpan™ SFEM II supports equivalent total nucleated cell expansion, and superior CD34+ cell expansion, compared to the existing highest performance serum-free media on the market,” said Dr. Bert Wognum, the senior scientist responsible for hematopoietic stem cell expansion medium development at STEMCELL Technologies. “It also supports erythroid and megakaryocyte expansion and may be used by researchers to develop and optimize their own culture systems to generate large numbers of other mature blood cells.”

“We are delighted to support hematopoietic stem cell researchers by providing StemSpan™ SFEM II, allowing them increased flexibility of experimental design for applications requiring large numbers of hematopoietic progenitors” said Dr. Allen Eaves, CEO and President of STEMCELL Technologies.

The high-quality StemSpan™ serum-free media products include StemSpan™ SFEM, StemSpan™ SFEM II, StemSpan™ H3000 and StemSpan™ ACF for ex vivo expansion of hematopoietic progenitor cells. For more information about StemSpan™ SFEM II and for technical resources on hematopoietic stem cell expansion, please visit our product page.

Contact

Isis Carter, PhD, Product Manager

STEMCELL Technologies Inc.

604.668.0875

About STEMCELL Technologies

STEMCELL Technologies Inc. is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research. As “Scientists Helping Scientists,” STEMCELL delivers over 1000 products to more than 70 countries worldwide and provides leadership with services including hands-on training courses, proficiency testing, and contract services. To learn more about how STEMCELL helps to make research work, visit www.stemcell.com.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->